By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Siamab Therapeutics 

90 Bridge Street
Suite 100
Newton  Massachussetts  02458  U.S.A.
Phone: 617-714-9773 Fax: 617-752-3653


SEARCH JOBS

Siamab Therapeutics is a biopharmaceutical company developing therapies targeting cancers that express abnormal carbohydrates/glycans. These highly cancer specific, tumor associated carbohydrate antigens (TACAs) are present in the majority of solid tumors including ovarian, pancreatic, prostate, colon, gastric, and breast, and are exploited by tumor cells to suppress innate immune function, enable tissue invasion and metastasis, resist chemotherapy, and promote a stem-cell phenotype. Therefore, therapeutic antibodies targeting TACAs have the potential to not only kill cancer cells but also re-engage the immune system and overcome chemo-resistance.

YEAR FOUNDED:

2006

LEADERSHIP:

CEO: Jeff Behrens


Key Statistics


Email: info@siamab.com
Ownership: Private

Web Site: Siamab
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->